Skip to content

Clinical trials

Phase 1/2 Lymphoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1/2 Country / region: Taiwan Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20171
20182
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dren Bio1
RAPT Therapeutics, Inc., a member of the GSK plc group of companies1
Sanofi1
Taiwan Liposome Company1
Tesaro, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma6
Carcinoma, Non-Small-Cell Lung2
Breast Neoplasms1
Carcinoma, Transitional Cell1
Enteropathy-Associated T-Cell Lymphoma1
Glioblastoma1
Glioma1
Granuloma, Plasma Cell1
Leukemia1
Leukemia, Large Granular Lymphocytic1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.